Tri-vylibra
Product Images NDC 53002-1776

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tri-vylibra (NDC 53002-1776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021776)

FDA Label Image

Norgestimate-fig1.jpg (Norgestimate Fig1)

FDA Label Image

Norgestimate-fig2 (Norgestimate Fig2)

FDA Label Image

Figure-3 (Norgestimate Fig3)

Figure-3 (Norgestimate Fig3)
This text is describing different methods of birth control and their effectiveness in preventing pregnancy. It provides ranges of the number of pregnancies per 100 women in one year for different methods, from fewer than 1 to 85 or more. The text lists several specific methods including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, withdrawal, and no birth control.*
FDA Label Image

Norgestimate-fig4 (Norgestimate Fig4)

FDA Label Image

Norgestimate-fig5 (Norgestimate Fig5)

FDA Label Image

Chemical Structure (Norgestimate Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.